Condition
Primary Renal Allograft Candidate
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
6 treatments under study, led by Tacrolimus
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
100.0%
1 terminated out of 1 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Terminated1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Tacrolimus1
- Methylprednisolone1
- Mycophenolate Mofetil1
- Belatacept1
- Basiliximab1
Active Sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)1
- Clinical Trials in Organ Transplantation1
Top Investigators
University of Alabama at Birmingham
Emory University
Related Conditions
- Kidney Transplantation1